Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Renee D. Gala currently holds 147,361 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Renee D. Gala has been a net seller of TBPH stock. They have purchased $276.8K and sold $2.6M worth of shares.
Renee D. Gala's most recent insider trade was on Jun 30, 2026, when they sold 4,835 shares at $237.72 per share.
Renee D. Gala serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 50 insider transactions totaling $2.9M over their tenure at the company.
Renee D. Gala holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Renee D. Gala has shown a selling trading pattern, with $276.8K in total purchases and $2.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Renee D. Gala was on Mar 5, 2026, when they sold $1.3M worth of JAZZ shares. This transaction involved 7,065 shares at $188.69 per share.
Renee D. Gala currently owns 147,361 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Renee D. Gala's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Renee D. Gala has 50 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Renee D. Gala and 40,000+ other insiders.